SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
8064166
Source:
http://linkedlifedata.com/resource/pubmed/id/8064166
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005823
,
umls-concept:C0022709
,
umls-concept:C0035094
,
umls-concept:C0085580
,
umls-concept:C0205178
,
umls-concept:C0348016
,
umls-concept:C0442027
,
umls-concept:C1280500
,
umls-concept:C1524081
pubmed:issue
4
pubmed:dateCreated
1994-9-20
pubmed:abstractText
To assess the participation of the renin-angiotensin system in the blood pressure regulation of essential hypertensive patients through acute specific renin inhibition.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8306882
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin I
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II
,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...
,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril
,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Renin
,
http://linkedlifedata.com/resource/pubmed/chemical/remikiren
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0263-6352
pubmed:author
pubmed-author:AziziMM
,
pubmed-author:ChatellierGG
,
pubmed-author:GuyeneT TTT
,
pubmed-author:MénardJJ
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
419-27
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8064166-Administration, Oral
,
pubmed-meshheading:8064166-Adult
,
pubmed-meshheading:8064166-Aged
,
pubmed-meshheading:8064166-Angiotensin I
,
pubmed-meshheading:8064166-Angiotensin II
,
pubmed-meshheading:8064166-Angiotensin-Converting Enzyme Inhibitors
,
pubmed-meshheading:8064166-Blood Pressure
,
pubmed-meshheading:8064166-Captopril
,
pubmed-meshheading:8064166-Female
,
pubmed-meshheading:8064166-Hemodynamics
,
pubmed-meshheading:8064166-Humans
,
pubmed-meshheading:8064166-Hypertension
,
pubmed-meshheading:8064166-Imidazoles
,
pubmed-meshheading:8064166-Injections, Intravenous
,
pubmed-meshheading:8064166-Male
,
pubmed-meshheading:8064166-Middle Aged
,
pubmed-meshheading:8064166-Renin
,
pubmed-meshheading:8064166-Time Factors
pubmed:year
1994
pubmed:articleTitle
Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
pubmed:affiliation
Broussais Hospital Clinical Investigation Centre, Assistance Publique des Hôpitaux de Paris, France.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't